• Aplicação Da Mcda Nas Tomadas De Decisão Sobre Investimento Em Saúde – Uma Revisão Sistemática

    Oct 1, 2017, 00:00

  • Economic Burden Of Hospitalized Diarrheal Disease In Bangladesh

    Oct 1, 2017, 00:00

  • Incidence, Mortality And Treatment Of Melanoma In Poland In The Years 2012–2016

    Oct 1, 2017, 00:00

  • Fast-Track Medication Refill (FTMR) Service Could Be More Cost-Effective Than The Current Model Of Care In Hong Kong

    Oct 1, 2017, 00:00

  • Impact of Collaborative Coustomized Patient Education in Psychiatric Diseases

    Oct 1, 2017, 00:00

  • Health Valuation of Dialysis with the EQ-5D- Determinants of Discrepancy Between Patients and Society

    Oct 1, 2017, 00:00

  • The Epidemiology Of Adult Immune (Idiopathic) Thrombocytopenic Purpura (ITP) In Finland- Resource Utilisation, Related Costs And Hospital Medication Associated With The Treatment Of Non-Splenectomised Adult Itp Based On Real World Data From ...

    Oct 1, 2017, 00:00

  • Gender Inequality In Acute Gastro-Enteritis Rates In England

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Standard Therapy with Phosphocreatine VS Standard Therapy In Perioperative Management of Cardiac Surgery Patients With Extracorporeal Circulation, With Ischemic Heart Disease or With Chronic Heart Insufficienc ...

    Oct 1, 2017, 00:00

  • Impact of Isocitrate Dehydrogenase (IDH) Status on the Performance Status and Quality of Life (QOL) of Glioblastoma Multiforme (GBM) Patients

    Oct 1, 2017, 00:00

  • Work Productivity in Brazilian Patients with Moderate-to-Severe Plaque Psoriasis

    Oct 1, 2017, 00:00

  • An Exploratory Comparison Of US And EU Approaches To Oncology Management. Are US Payers Ready For Management Tools Incorporating HTA Methodologies?

    Oct 1, 2017, 00:00

  • Quantity And Quality Of External Event Validation Procedures Performed In Published Health Economic Models In Obesity- Outcomes Of A Systematic Review

    Oct 1, 2017, 00:00

  • Coverage-With-Evidence-Development (CED) In Germany- Status QUO

    Oct 1, 2017, 00:00

  • Cost-Savings In Process Innovations; A Case Example In Myocardial Infarction Patients

    Oct 1, 2017, 00:00

  • Indicators of Participation in Cervical Cancer Screening Among Romany Women

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Afatinib, Gefitinib, Erlotinib, and Pemetrexed-Based Chemotherapy as First-Line Treatments for Egfr Mutation Positive, Advanced Non-Small Cell Lung Cancer in China

    Oct 1, 2017, 00:00

  • How Much Sexual Violence Against Women Costs To Brazil?

    Oct 1, 2017, 00:00

  • Estimate European Candidates For Bronchoscopic Lung Volume Reduction (BLVR) Technologies In The Treatment Of Severe Emphysema

    Oct 1, 2017, 00:00

  • The Economic Impact of Dietary Sodium Reduction In Canada

    Oct 1, 2017, 00:00

  • Variation In Opioid Utilization By Physician Specialty And Payer Using A Linked Claims-Emr Database

    Oct 1, 2017, 00:00

  • The Two-Year Therapy with Omalizumab in Children with Severe Persistent Uncontrolled Asthma- Dynamics of Quality of Life

    Oct 1, 2017, 00:00

  • Variation Trend of Annual Medical Cost Forseveralkinds of Malignant Tumors in China- Analysis Based on A Regional Public Health Insurance Claim Database (2011-2015)

    Oct 1, 2017, 00:00

  • Comparing The Estimated Health And Economic Benefits Of Herpes Zoster (HZ) Vaccines In The UK

    Oct 1, 2017, 00:00

  • Value Health With A Mobile APP- The Infant Health-Related Quality Of Life Instrument

    Oct 1, 2017, 00:00

  • Predicting Budget Impact- A Mixed-Effects Model Approach

    Oct 1, 2017, 00:00

  • A Cost Per Responder Analysis of Secukinumab Vs. Adalimumab Based on a Matching-Adjusted Indirect Comparison of Efficacy Data for the Treatmetn of Psoriatic Arthritis at 48 Weeks from the Irish Payer Perspective

    Oct 1, 2017, 00:00

  • Probabilistic Sensitivity Analysis And Its Role In Assessment Of Profitability In Poland

    Oct 1, 2017, 00:00

  • The Impact Of Co-Morbidity On The Disease Burden Of VTE

    Oct 1, 2017, 00:00

  • ALK Immunohistochemical Test In The Detection Of Patients Affected By ALK+ Non-Small Cell Lung Cancer- Clinical And Budget Impact

    Oct 1, 2017, 00:00

  • Repellent And Larvicidal Activity Of Thai Medicinal Plants Against Mosquitoes- A Systematic Review And Meta-Analysis

    Oct 1, 2017, 00:00

  • Evaluation Of Wearable Technology Use In Clinician Outcomes Assessment Studies

    Oct 1, 2017, 00:00

  • Smoking Cessation Interventions Based on Social Marketing Principles- A Review

    Oct 1, 2017, 00:00

  • Assessment of Medicines For Very Rare Conditions- Review of A New Approach within The Scottish Medicines Consortium

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Surgical Approaches Total HIP Arthroplasty

    Oct 1, 2017, 00:00

  • Providing A Framework For Assessing Access To Medicine

    Oct 1, 2017, 00:00

  • Economic Evaluation of A Patient Support Programme Abbvie Care 2.0 Immunology

    Oct 1, 2017, 00:00

  • A Systematic Review Of Economic Evaluations In Robot-Assisted Hysterectomy Use For Cervical Cancer Compared With Open And Laparoscopic Surgery

    Oct 1, 2017, 00:00

  • Abaloparatide For Risk Reduction of Nonvertebral And Vertebral Fractures In Postmenopausal Women With Osteoporosis- A Network Meta-Analysis

    Oct 1, 2017, 00:00

  • Evaluating the Long-Term Impact of Improving Care for Patients with Type 2 Diabetes in China

    Oct 1, 2017, 00:00

  • Estimating The Reference Icer For Australia And Public Perceptions Toward Its Use

    Oct 1, 2017, 00:00

  • Secukinumab Vs. Adalimumab for the Treatment of Psoriatic Arthritis- A Cost Per Responder Analysis at 48 Weeks from an Argentinian Perspective

    Oct 1, 2017, 00:00

  • Generic Competition and ITS Impact on Reference Pricing System and Medicnes Utilization in the Group of Sartans

    Oct 1, 2017, 00:00

  • What Are The Images Used To Diagnose And Assess Suspected Strokes?- A Systematic Literature Review Of Care In Four European Countries

    Oct 1, 2017, 00:00

  • Hematopoietic Cell Transplantation Facilities- Geographic Access in Colombia

    Oct 1, 2017, 00:00

  • Health-Related Quality of Life of Patients with Osteoporosis Treated with Teriparatide

    Oct 1, 2017, 00:00

  • One Year Cost Of Ischemic Stroke And Intracranial Hemorrage According To Disability For Atrial Fibrillation Patients In France

    Oct 1, 2017, 00:00

  • Application Study of the EQ-5D-5L in Oncology- Linking Self-Reported Quality of Life of Patients with Metastatic Colorectal Cancer to Clinical Data from a German Tumor Registry

    Oct 1, 2017, 00:00

  • Open To The Public? A Comparative Analysis Of Data Published Under The “Ema Policy On The Publication Of Clinical Data” And Dossiers For Early Benefit Assessments In Germany

    Oct 1, 2017, 00:00

  • Psoriasis Drugs in Europe - Market Access Decisions in Comparision Based on the Prismaccess Database

    Oct 1, 2017, 00:00

  • Health-Related Quality of Life in Patients with Metastatic Colorectal Cancer Using EQ-5D-5L

    Oct 1, 2017, 00:00

  • Health-Related Quality of Life in Oncology – Are we Getting Better?

    Oct 1, 2017, 00:00

  • Burden of Chronic Heart Failure on Caregivers- A Multinational Cross-Sectional Survey in Real World Setting

    Oct 1, 2017, 00:00

  • Burden Of Illness Of Pulmonary Embolism In Europe – Healthcare Resource Utilization And Productivity Loss

    Oct 1, 2017, 00:00

  • Non-Proportional Hazards in Network Meta-Analysis- Efficient Strategies for Model Building and Analysis

    Oct 1, 2017, 00:00

  • Risky Business- What Factors Influence Decision-Maker’s Willingness to Pay for New Treatments on the Hospital Formulary?

    Oct 1, 2017, 00:00

  • Market Access Trends Across The EU5- 2009 To 2016- An Update

    Oct 1, 2017, 00:00

  • Economic Evaluation Of Ayahuasca Treatment For Substance Use Disorder (SUD) Patients In A Peruvian Centre

    Oct 1, 2017, 00:00

  • Impact of End-Stage Renal Disease on Health Economic Outcomes of Hyperkalaemia Management In Patients With Chronic Kidney Disease

    Oct 1, 2017, 00:00

  • Novel Biologics Versus Conventional Preventive Therapies In Migraine- A Framework for Economic Evaluation

    Oct 1, 2017, 00:00

  • The Resource Cost of Switching Stable Rheumatology Patients From An Originator Biologic To A Biosimilar In The UK

    Oct 1, 2017, 00:00

  • Comparing The Healthcare Cost Utilization Of Paediatric Patients With Haemophilia A With And Without Inhibitors Treated At Instituto De Seguridad Social Del Estado De Mexico Y Municipios

    Oct 1, 2017, 00:00

  • Switching of Biological Drugs in Rheumatoid Arthritis- A Cohort of Users from the Brazilian Public Health System

    Oct 1, 2017, 00:00

  • Economic and Humanistic Burden of Illness Amongst Diabetes Patients Experiencing Treatment Inertia

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of Primary HPV Screening With Dual-Stain Cytology Triage In The Cervical Cancer Screening Program Of Belgium

    Oct 1, 2017, 00:00

  • Economic Evaluation of the Change from An Opportunistic Cervical Screening Program to an Organized Screening in Catalonia, Spain

    Oct 1, 2017, 00:00

  • Validity and Interpretation of A Skin Pain Numeric Rating Scale Among Adults and Adolescents With Atopic Dermatitis

    Oct 1, 2017, 00:00

  • Web App Estimating Cost Savings And Clinical Outcomes Of Blood Glucose Monitoring Program. Example From The UK

    Oct 1, 2017, 00:00

  • Budget Impact of Post-Stroke Dysphagia- Database Analyses of Hospital Discharges In France And Switzerland

    Oct 1, 2017, 00:00

  • Skin Pain In Psoriasis

    Oct 1, 2017, 00:00

  • Access To Medicines For Rare Diseases In Australia- The Current Climate For Reimbursement

    Oct 1, 2017, 00:00

  • The Personalised Reimbursement Models (Prm)- Real World Data Collection to Provide Innovative Pricing Solutions in France

    Oct 1, 2017, 00:00

  • Patient-Reported Outcomes In Labels And Package Leaflets Of Drugs Approved By The European Medicines Agency From 2007 To 2017

    Oct 1, 2017, 00:00

  • Crosslinking to Corneal Keratoconus

    Oct 1, 2017, 00:00

  • Treatment Cost Comparison of Pirfenidone Versus Nintedanib on The Treatment of Idiopathic Pulmonary Fibrosis

    Oct 1, 2017, 00:00

  • Multiple Myeloma Patients’ Profile and Regimens Transitions in the Brazilian Private Health Sector

    Oct 1, 2017, 00:00

  • A Longitudinal Pattern of Care for Prostaglandin Prescription for Glaucoma In Korea

    Oct 1, 2017, 00:00

  • Health Related Quality Of Life For Systemic Juvenile Idiopathic Arthritis (SJIA) Patients And Caregivers On Biologic Therapy, From A Caregiver’s Perspective

    Oct 1, 2017, 00:00

  • Newest Target Therapy And Immunotherapy for the Treatment of Advanced Melanoma- Patterns of Adoption By the Private Health Care Sector in Brazil

    Oct 1, 2017, 00:00

  • Estimation of Prevalence In Rare Disease

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Additional Human Papillomavirus Vaccination Programmes, in The Netherlands

    Oct 1, 2017, 00:00

  • Multiple Source of Information to Characterize the Clinical, Therapeutic Management and Economic Burden of Patients with Multiple Sclerosis in France

    Oct 1, 2017, 00:00

  • The Clinical and Cost Effectiveness of Dasatinib Versus Nilotinib for The First and Second Line Treatment of People with Chronic Myeloid Leukaemia

    Oct 1, 2017, 00:00

  • Are Accelerated Approval Mechanisms A Predictor To Early Access And Coverage? A Global Study Of Cancer Drugs

    Oct 1, 2017, 00:00

  • Risk of Acute Exacerbation and Severe Acute Exacerbation Associated With Different Severities of Copd At Diagnosis- A Prospective Cohort Study in Korea

    Oct 1, 2017, 00:00

  • Long-Term Cost-Effectiveness of Ideglira Versus Basal-Bolus Insulin As Intensification Therapies For People With Type 2 Diabetes Inadequately Controlled on Basal Insulin In Spain- Projections Based On The Dual VII Trial

    Oct 1, 2017, 00:00

  • Costo Medico Directo Atribuible Al Tratamiento De Pacientes Con Neoplasia Intraepitelial Cervical (CIN) 2 Morfológico E Impacto Económico Del Diagnóstico Diferencial Con Biomarcador P16 En Una Institución Privada De La Ciudad De Buenos Aire ...

    Oct 1, 2017, 00:00

  • The Comparison of EQ-5D-5L Versus Disease/Treatment-Specific Measures in Pulmonary Embolism and Deep Vein Thrombosis

    Oct 1, 2017, 00:00

  • Comorbidity Indices Based On Health-Related Quality Of Life Are More Strongly Associated With Patient Outcomes Than Mortality-Based Indices

    Oct 1, 2017, 00:00

  • Elasticidad Precio De La Demanda Para Explorar Medidas Impositivas Que Desalienten EL Consumo De Bebidas Azucaradas Y Contribuyan a Prevenir Obesidad Y Diabetes Tipo II

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Reperfusion Strategies For St-Elevation Myocardial Infarction. Real-World Data From The Stent For Life Initiative In Italy

    Oct 1, 2017, 00:00

  • Integrating Novel Screening Methods For Prostate Cancer, Cost-Utility Interventions

    Oct 1, 2017, 00:00

  • Employment Relationship And Glycemic Control In Type 2 Diabetes Patients

    Oct 1, 2017, 00:00

  • Cost Study Of Immune Thrombocytopenia (ITP) Management From The French Hospital Perspective

    Oct 1, 2017, 00:00

  • Guidance for Developing A Study Protocol of A Causal Comparative Effectiveness Analysis in “Big Data”- The Case of When To Start Statin Treatment

    Oct 1, 2017, 00:00

  • Amnog Dossiers As A Challenge for Pharmaceutical Companies- Is There A Correlation Between Volumes and Added Medical Benefit?

    Oct 1, 2017, 00:00

  • The Cost-Effectiveness of Varicella Vaccination In Peru

    Oct 1, 2017, 00:00

  • Beyond Product Value - A Holistic Approach For Value Assessment

    Oct 1, 2017, 00:00

  • Comparative Evaluation of the Efficacy of Herbal and Nonsteroidal Anti-Inflammatory Drugs in the Treatment of Dysmenorrhea in Women With Female Reproductive Tract Congenital Anomalies

    Oct 1, 2017, 00:00

  • Costs And Effectiveness Of An Integrated Care Intervention For Muscle-Skeletal Diseases Transition From Primary Care To Specialized Hospital Care

    Oct 1, 2017, 00:00

  • Determining The Shares of The Cost of Anesthesia And Intensive Care Medicine In Stationary And Stationary Part And Their Development Since 2006 In Germany

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Nivolumab (NIVO) Combined with Ipilimumab (IPI) Compared with Nivo and Ipi Monotherapies in The First-Line Treatment of Advanced Melanoma in The United States- Analysis Using 28-Month Overall Survival (OS) Data from Ch ...

    Oct 1, 2017, 00:00

  • Assessing The Burden Of Chronic Heart Failure (Chf) On Patients’ Caregivers In Mexico

    Oct 1, 2017, 00:00

  • The Attitude Of Parents To Non-Mandatory Vaccinations

    Oct 1, 2017, 00:00

  • Costo De Eventos Coronarios Agudos En Población Con Factores De Riesgo Cardiovascular- Análisis Retrospectivo

    Oct 1, 2017, 00:00

  • A Robust, Reproducible Method For Evaluating The Suitability of Disparate Observational Databases for Pooled Analysis, Using The Omop Common Data Model

    Oct 1, 2017, 00:00

  • Access to New Treatments For Chronic Hepatitis C in Four Latin American Countries

    Oct 1, 2017, 00:00

  • Comparison of Persistence And Adherence In Biologic Naïve Patients With Psoriatic Arthritis Initiating Apremilast or Biologics In A US Administrative Claims Database

    Oct 1, 2017, 00:00

  • Economic Evaluation of using a Combination of Helicobacter Pylori Antibody and Serum Pepsinogen Levels for Gastric Cancer-Risk Screening in Japan

    Oct 1, 2017, 00:00

  • Factors Influencing Innovative Drug Reimbursement In Poland

    Oct 1, 2017, 00:00

  • Assessing Cost-Effectiveness And Key Value Drivers of Adjuvant Triglyceride Lowering Therapy In Management of Patients with A Rare Genetic Syndrome

    Oct 1, 2017, 00:00

  • Study Of Polypharmacy At A Tertiary Care Teaching Hospital Bangalore

    Oct 1, 2017, 00:00

  • Economic Impact Of Atopic Dermatitis In Adults- A Population Study (Idea Study)

    Oct 1, 2017, 00:00

  • Understanding Patients’ Ability to Function in Order to Inform Clinical Benefit in Oncology Studies

    Oct 1, 2017, 00:00

  • Using Electronic Health Records As A Real World Comparator- A Case Study In A Single Arm Oncology Trial

    Oct 1, 2017, 00:00

  • Quality of Life (QOL), Functional Status (FS), and Survival in Triple Negative Breast Cancer (TNBC)- Discordance of Definitions Among a Targeted Literature Review and Stakeholder Interviews

    Oct 1, 2017, 00:00

  • One Size Does Not Fit All- What Are The Appropriate Screening Intervals For People At Risk Of Diabetic Retinopathy

    Oct 1, 2017, 00:00

  • Denosumab And Bisphosphonates Persistence, Compliance And Switch In Patients With Solid Tumors (ST) And Bone Metastases (BM)

    Oct 1, 2017, 00:00

  • Reducing Cognitive Burden In Discrete Choice Experiments

    Oct 1, 2017, 00:00

  • Qualitative Interviews To Inform Development Of A Patient Reported Outcome (PRO) Strategy In RLBP1 Retinitis Pigmentosa (RLBP1 RP)

    Oct 1, 2017, 00:00

  • Geografia Do Gasto Público COM Nefrologia No Brasil 2013 A 2016

    Oct 1, 2017, 00:00

  • Using Rasch Measurement To Quantify The Perceived Risks Associated With The Use Of Tobacco And Nicotine-Containing Products

    Oct 1, 2017, 00:00

  • Single Versus Multiple Inhalers in Patients with Chronic Obstructive Pulmonary Disease (COPD)- A Systematic Literature Review

    Oct 1, 2017, 00:00

  • Estimation Of The Cost Of Relapse In Schizophrenia- A Comparison Between Colombia, Panama And Mexico

    Oct 1, 2017, 00:00

  • Reported Utilities for Patients with Untreated Advanced/Metastatic Renal Cell Carcinoma – A Systematic Literature Review

    Oct 1, 2017, 00:00

  • Differences In Labour Participation Between People Living With HIV And The General Population- Results From Spain Along The Business Cycle

    Oct 1, 2017, 00:00

  • How Should We Value Orphan Drugs? Suggestions From A Large Public Opinion Survey

    Oct 1, 2017, 00:00

  • A Budget Impact Analysis of An Increased Uptake of Alemtuzumab From The UK NHS Perspective

    Oct 1, 2017, 00:00

  • Incidence and Prevalence of Painful Diabetic Neuropathy and Postherpetic Neuralgia in Major 5 European Countries, the United States and Japan

    Oct 1, 2017, 00:00

  • Estimating The Number of Relapsed And Refractory Indolent Lymphoma Patients Across Europe, Who Are Expected To Initiate A New Line of Therapy (LOT)

    Oct 1, 2017, 00:00

  • Patient-Reported outcomes from Phase 3 Baricitinib Ra-Begin Study- Latin American Subgroup Analysis

    Oct 1, 2017, 00:00

  • Are There Differences in Fact-G Scores Between Different Tumour Types for an EU Population Using Real World Data?

    Oct 1, 2017, 00:00

  • Pump-Downloaded Insulin Usage For The First 12 Months In A Cohort of Children Newly-Diagnosed With Type 1 Diabetes (T1D)

    Oct 1, 2017, 00:00

  • Multi-Disciplinary Decision Making In General Practice- A Case Study Of Switching Between Oral Anticoagulants

    Oct 1, 2017, 00:00

  • Epidemiology of Psoriasis In Colombia- A Governmental Database Analysis

    Oct 1, 2017, 00:00

  • Evaluating The Economic Burden And Health Care Utilization Of Bacterial Pneumonia In The US Department Of Defense Population

    Oct 1, 2017, 00:00

  • Value Frameworks For Cancer Care- Do They Account For Potential Durable Survival With Immunotherapy?

    Oct 1, 2017, 00:00

  • Health Care Resource Utilization And Costs Associated With HIV-Positive Patients With Comorbidity Versus HIV-Negative Patients With Comorbidity

    Oct 1, 2017, 00:00

  • Cost-Minimization of Adalimumab and Infliximab In Patients With Moderate To Severe Ulcerative Colitis Refractory To Conventional Therapy

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of A Polypill for Patients with or at High Risk of Cardiovascular Disease in an NHS Setting

    Oct 1, 2017, 00:00

  • Budget Impact of IV Iron Therapy with Ferric Carboxymaltose In Patients with Chronic Heart Failure And Iron Deficiency In France

    Oct 1, 2017, 00:00

  • Are Patient Outcomes Being Relegated By Nices Budget Impact Test?

    Oct 1, 2017, 00:00

  • Severity Of Kidney Disease In Systemic Lupus Erythematosus

    Oct 1, 2017, 00:00

  • Rare Diseases, Are Caregivers Just As Affected As Patients?

    Oct 1, 2017, 00:00

  • Economic Burden Of Vaccine Preventable Infectious Diseases Among Elderly Patients In Dutch Hospitals

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of A Potential Combined Vaccine Against Lyme Borreliosis And Tick-Borne Encephalitis In Slovenia

    Oct 1, 2017, 00:00

  • Burden Of Cardiovascular Disease (CVD) For Patients With Familial Hypercholesterolemia (FH) Or Atherosclerotic Cardiovascular Disease (ASCVD) And The Impact Of Reducing Low Density Lipoprotein-Cholesterol (LDL-C) Lowering In Latin American ...

    Oct 1, 2017, 00:00

  • Tratamento Clínico De Obesidade Através De Internações Clínicas Em Spa- Impacto Econômico Da Judicialização

    Oct 1, 2017, 00:00

  • Evidence Map of Costs Studies In Cystic Fibrosis Since 2000

    Oct 1, 2017, 00:00

  • Insight Into the Role of the General Practitioner in the Management of Colorectal Cancer- Record Linkage of the Netherlands Cancer Registry and the General Practitioner Database of the Pharmo Database Network

    Oct 1, 2017, 00:00

  • Clinical Comparison of First-Line Platin Chemotherapy Regimens In Patients With Advanced Nonsquamous Non-Small Cell Lung Cancer (NSCLC) Using German Registry Data

    Oct 1, 2017, 00:00

  • A Systematic Review of Corticosteroids’ Role in the Management of Urolithiasis Patients

    Oct 1, 2017, 00:00

  • Burden Disease of Aortic Stenosis Associated in Patients Undergoing Transcatheter Aortic Valve Replacement

    Oct 1, 2017, 00:00

  • Cost Analysis Of Delivery Neonatal Drug Therapy Services At Ministry Of Health In Saudi Arabia

    Oct 1, 2017, 00:00

  • The Impact of Disease Duration and Disease Activity on the Cost of Rheumatoid Arthritis- Results from Burden of Rheumatoid Arthritis Across Europe a Socioeconomic Survey (BRASS)

    Oct 1, 2017, 00:00

  • A Novel Atrial Fibrillation Evaluation Modelling Solution For NHS

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Alectinib Compared To Chemotherapy for The Treatment of Treatment-Naïve Patients With Alk Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) in Greece

    Oct 1, 2017, 00:00

  • Development And Content Validity Testing Of An Assessment Of Symptoms And Experiences Of Patients With Acute Pancreattis Associated With Severe Hypertriglyceridemia

    Oct 1, 2017, 00:00

  • Merkel Cell Cancer- Poor Response To Chemotherapy Exposes Significant Unmet Need

    Oct 1, 2017, 00:00

  • Assessing the Value of Decision Trees As A Method for Identifying Patient Subgroups

    Oct 1, 2017, 00:00

  • How does high meld score increases total expenditure on health system? A micro-costing prospective cohort study

    Oct 1, 2017, 00:00

  • Minimal Impact on Patients’ Health Utilities Associated with Adverse Events in Metastatic Merkel Cell Carcinoma Patients on Treatment with Avelumab

    Oct 1, 2017, 00:00

  • Secukinumab vs Adalimumab for The Treatment of Psoriatic Arthritis- A Cost Per Responder Analysis At 48 Weeks from A Chilean Perspective

    Oct 1, 2017, 00:00

  • Attitude Of Pharmacy Educators Towards Complementary And Alternative Medicines (CAM) Education In Pharmacy Curriculum- A Qualitative Exploration

    Oct 1, 2017, 00:00

  • Mejoramiento De Los Resultados Clínicos En Pacientes Con Reemplazos De Cadera Y Rodilla

    Oct 1, 2017, 00:00

  • Assessment and Comparison of National and International Regulations On Registration Of Biosimilars

    Oct 1, 2017, 00:00

  • Systematic Literature Review On Multi-Indication Pricing Models In Oncological Drugs

    Oct 1, 2017, 00:00

  • The Economic Impact Of Fibrin Sealants Used For Hemostasis In Coronary Artery Bypass Grafting Surgery; An Italian Perspective

    Oct 1, 2017, 00:00

  • Analysis of Real Data for Treatment of Preterm Birth in Pregnant in Ukraine

    Oct 1, 2017, 00:00

  • Modelo Económico De Estimación De Gasto Farmacéutico En UNA Aseguradora Colombiana

    Oct 1, 2017, 00:00

  • Assessing The Real-World Hospital Economic Burden Of Spinal Muscular Atrophy (SMA) In France

    Oct 1, 2017, 00:00

  • Iron Deficiency Anemia In Patients With Chronic Inflammatory Bowel Disease (IBD)- A Systematic Literature Review

    Oct 1, 2017, 00:00

  • Psychometric Properties Of The EQ-5D-5L In Patients With Major Depression Disorder

    Oct 1, 2017, 00:00

  • Risk of Major Osteoporotic Fracture (Hip, Vertebral, Radius, Humerus [MOF]) After First, Second and Third Fragility Fracture In A Swedish General Population Cohort

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Enstilar® for The Treatment of Psoriasis In Italy

    Oct 1, 2017, 00:00

  • Using Mathematical Optimisation In Model-Based Cost-Effectiveness Analyses- A Case Study Of A Stratified Breast Screening Programme

    Oct 1, 2017, 00:00

  • How To Aggregate Various Values of Medical Devices Innovation?; A Review of Empirical Work

    Oct 1, 2017, 00:00

  • Assessing Comparability and Patient Profile of Two Claims Databases in Oncology in Brazil

    Oct 1, 2017, 00:00

  • EQ-5D-5L Population Norms For Moscow (Russia)- Interim Analysis

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis For The Treatmet with Daclatasvir-Asunaprevir in Patients Naive with Chronic Hepatitis C Genotype 1b Without Baseline Ns5a Polymorphisms Under The Public Payer Perspective in Mexico

    Oct 1, 2017, 00:00

  • Digital Real-World Evidence Platform- Taking the Burden Out of Melanoma Pain Reporting

    Oct 1, 2017, 00:00

  • A Cost-Effectiveness Analysis of Vaccinating The Elderly with The 23-Valent Pneumococcal Polysaccharide Vaccine (Ppv23) Compared To No Vaccination, The 13-Valent Pneumococcal Conjugate Vaccine (Pcv13), or Pcv13 Followed by Ppv23 in Brazil

    Oct 1, 2017, 00:00

  • Preferences for Route of Administration, Frequency and Location – A Time-Trade-Off Study in the United Kingdom General Population

    Oct 1, 2017, 00:00

  • Relative Efficacy and Tolerability of Lacosamide Versus Levetiracetam as Monotherapy for Adults with Newly Diagnosed Focal Seizures- A Post-Hoc Analysis of Randomized Clinical Trials

    Oct 1, 2017, 00:00

  • Analysis of Factors Influencing the Level of Actual Benefit in Health Technology Assessment

    Oct 1, 2017, 00:00

  • A Comprehensive Assessment of The HTA Landscape For Reimbursement of Rheumatoid Arthritis Drugs- Pitfalls and Challenges In Gaining Successful Approvals

    Oct 1, 2017, 00:00

  • Seleção Sistemática De Coortes Em Bases De Dados Assistenciais

    Oct 1, 2017, 00:00

  • Cost-Utility Evaluation Of Insulin Glargine (300 U/ML) Versus Insulin Glargine (100 U/ML) And Insulin Degludec (100 U/ML) IN Patients With Type 2 Diabetes Mellitus In Serbia

    Oct 1, 2017, 00:00

  • Antibiotic Prescribing Pattern In Acute Upper Respiratory Tract Infections In Dubai

    Oct 1, 2017, 00:00

  • Análisis Multicriterio Del Uso De Dos Líquidos Dializantes Para Hemodiálisis En Perú

    Oct 1, 2017, 00:00

  • Observed Versus Estimated Acquisition Costs Associated with Medicines Recommended by the All Wales Medicines Strategy Group

    Oct 1, 2017, 00:00

  • Systematic Literature Review For Treatment Outcomes (Including Immuno-Oncology Treatment) Among Patients with Stage 3 Unresectable Non-Small Cell Lung Cancer (NSCLC)

    Oct 1, 2017, 00:00

  • The Economic Burden of Breast Cancer in Russia

    Oct 1, 2017, 00:00

  • Does Ccg Spending on Cancer Affect Outcomes in Breast and Lung Cancer?

    Oct 1, 2017, 00:00

  • An Analysis of Health-Related Quality of Life in People with Multiple Sclerosis in Ireland

    Oct 1, 2017, 00:00

  • Adherence to Anti-Convulsant Therapy Among Ambulatory Epileptic Patients in a Tertiary Hospital in Nigeria

    Oct 1, 2017, 00:00

  • Resultados De La Implementación De Una Estrategia Combinada De Educación Y Gestión De Pacientes En Centros De Atención Primaria De Argentina

    Oct 1, 2017, 00:00

  • Economic Evaluation of Flash Glucose Monitoring Compared To Self - Monitoring of Blood Glucose For The Management of Patients Receiving Intensive Insulin With Diabetes Type 1 And Type 2 In Greece

    Oct 1, 2017, 00:00

  • Economic Burden Associated with Skeletal-Related Events in Patients with Bone Metastases in Colombia

    Oct 1, 2017, 00:00

  • The Evaluation Of Assumptions In Cost-Effectiveness Model Development – A Case Of Dabigatran

    Oct 1, 2017, 00:00

  • A Comparison Of Markov Cohort And Discrete Event Simulation Models In Cost-Effectiveness Analysis Of Sorafenib And Everolimus In 3rd Line Metastatic Renal-Cell Carcinoma In The Czech Republic

    Oct 1, 2017, 00:00

  • Real-World Health-Related Quality of Life Eq-5d-5l Outcomes In Ankylosing Spondylitis (AS)- Analysis of Data From The Uk British Society For Rheumatology Register In Ankylosing Spondylitis (BSRBR-AS) Study

    Oct 1, 2017, 00:00

  • Impairment of Work Ability In Patients With Rheumatoid Arthritis

    Oct 1, 2017, 00:00

  • Does the Real-World use of Pharmacological Therapy Follow Guidelines in Coronary Artery Disease Patients in Finland?

    Oct 1, 2017, 00:00

  • German Amnog Benefit Assessment- The Type Of Appropriate Comparator Makes The Difference

    Oct 1, 2017, 00:00

  • Adherence Issues In Rheumatoid Arthritis Treatment- How Can Acceptance Measurement Help Understanding Patients’ Concerns And Working on Solutions?

    Oct 1, 2017, 00:00

  • Between-Hospital Variation of In-Hospital Mortality and 30-Day Readmissions in Acute Myocardial Infarction in Portugal- 2012-2014

    Oct 1, 2017, 00:00

  • Clinical And Economic Outcomes Of Microinvasive Glaucoma Surgery (MIGS) With Stents In Patients With Mild-To-Moderate Or Refractory Glaucoma In Spain

    Oct 1, 2017, 00:00

  • Understanding Stakeholder Expectations for Patient Engagement- A Qualitative Survey

    Oct 1, 2017, 00:00

  • The Economic Burden of Different Multiple Sclerosis Phenotypes

    Oct 1, 2017, 00:00

  • Does The Early Bird Catch The Worm- Early Cancer Detection And Survival In The UK

    Oct 1, 2017, 00:00

  • The Impact of Increase in The Proportion of Early Breast Cancer Cases on Costs and Outcomes

    Oct 1, 2017, 00:00

  • Costs of Grade 3 and 4 Adverse Events Associated with Current Cancer Treatments - Cost Estimations For Sweden, Norway, Finland And Denmark

    Oct 1, 2017, 00:00

  • Treatment Satisfaction and Burden of Illness With Oral Vs Injectable Multiple Myeloma Therapy in Patients with Newly Diagnosed Disease (NDMM)

    Oct 1, 2017, 00:00

  • Direct Costs Of Inflammatory Bowel Diseases Therapy In Poland - Nationwide Database Analysis

    Oct 1, 2017, 00:00

  • Efectividad De Las Intervenciones En Cultura De Seguridad Del Paciente En Las Instituciones Hospitalarias- Revisión Sistemática

    Oct 1, 2017, 00:00

  • Economic Analysis And Evaluation Of The Value Of The Parallel Export Of Medicinal Products For Treatment Of Oncological Diseases In Bulgaria, 2016 T. VEKOV 1 AND G. KOLEV2

    Oct 1, 2017, 00:00

  • Patient and Tumor Profiles in The Brazilian Private Setting- Data from The Auditron Claims Database

    Oct 1, 2017, 00:00

  • Trucs And CAR-TS - The Emergence Of Io Cell Therapies

    Oct 1, 2017, 00:00

  • Can Missing Data Boundary Estimates Cast Doubt On Previous Conclusions Reevaluating A 10 Year Cost-Effectiveness Analysis (CEA) Of The Diabetes Prevention Program Outcomes Study (DPP/DPPOS)?

    Oct 1, 2017, 00:00

  • Using A Mixed Methods Approach To Determine The Item-Scale Structure and Scoring for Clinical Outcome Assessments

    Oct 1, 2017, 00:00

  • Safety And Effectiveness of Insulin Analogues Versus Human Insulin In Type 2 Diabetes; A Systematic Review And Meta-Analysis

    Oct 1, 2017, 00:00

  • Análise Situacional Do Tratamento Cirúrgico Do Câncer Colorretal No Brasil

    Oct 1, 2017, 00:00

  • Strategies To Effectively Prevent Surgical Site Infections In Italian Hospitals- Economic Benefits

    Oct 1, 2017, 00:00

  • A Web-Based Hub Spoke Model For The Management Of HCV Patients And Innovative Treatments- The Resist - HCV Sicily Network Experience

    Oct 1, 2017, 00:00

  • Burden of Lysosomal Acid Lipase Deficiency

    Oct 1, 2017, 00:00

  • Economic Evaluation of Nivolumab (NIVO) Plus Ipilimumab (IPI) Combination as First-Line Treatment for Patients with Advanced Melanoma in Canada

    Oct 1, 2017, 00:00

  • Quality of Life of Asthma Patients In Gree What Can We Do to Improve It?

    Oct 1, 2017, 00:00

  • Potential Therapeutic and Economic Value of Risk-Stratified Treatment as Initial Treatment of Multiple Myeloma in Europe

    Oct 1, 2017, 00:00

  • Do Nice Appeals Make A Difference? Impact of Appeals on Appraisal Outcomes

    Oct 1, 2017, 00:00

  • Epidemiology and Clinical Characterisation of Obsessive- Compulsive Disorder in Bahawalpur Pakistan

    Oct 1, 2017, 00:00

  • The Impact Of Patient Preference Studies In The German Healthcare System

    Oct 1, 2017, 00:00

  • Cost-Utility Analysis of Rhtnk-TPA Compared With RT-PA In The Treatment of Acute St-Segment Elevation Myocardial Infarction (Stemi) In China

    Oct 1, 2017, 00:00

  • Investigating Comparator Requirements For Drug Selection For Cost-Effectiveness

    Oct 1, 2017, 00:00

  • Meta-Análise De Eficácia Da Atomoxetina Em Adultos com Transtorno De Déficit Da Atenção Com Hiperatividade

    Oct 1, 2017, 00:00

  • Real World Treatment Patterns In Metastatic And/Or Unresectable Gastric Cancer Patients In Russia

    Oct 1, 2017, 00:00

  • Burden and Cost of Cancer Treatment in the Private Healthcare Setting in São Paulo State

    Oct 1, 2017, 00:00

  • Investigation of Demographic Differences for Non-Small Cell Lung Cancer Patients with and Without Type 2 Diabetes

    Oct 1, 2017, 00:00

  • National Survey Of Medication Safety Practice At Ministry Of Health Hospitals During Mass Gathering (Hajj-2016) In Saudi Arabia

    Oct 1, 2017, 00:00

  • Incidence of Respiratory Syncytial Virus Related Healthcare Utilization In The United States

    Oct 1, 2017, 00:00

  • Agreement Between Patient And Clinician Ratings Of Disease Severity In Hidradenitis Suppurativa, Rheumatoid Arthritis, And Chronic Plaque Psoriasis

    Oct 1, 2017, 00:00

  • Assessment Of Health Technology Appraisals To Identify Key Drivers For Reimbursement Of Oncology Drugs With Only Phase 2 Clinical Data

    Oct 1, 2017, 00:00

  • Transsexual’s Sex Reassigment Process In Brazilian National Health System- Where Are We?

    Oct 1, 2017, 00:00

  • Outcomes of Disease Activity In Rheumatoid Arthritis and Health Insuran Results From Real World

    Oct 1, 2017, 00:00

  • Economic Burden of Hospitalizations Related To Pulmonary Arterial Hypertension (PAH) In France

    Oct 1, 2017, 00:00

  • Role of Chemotherapy In The Current Treatment of Metastatic Melanoma

    Oct 1, 2017, 00:00

  • Analysis Of The Reimbursement Amount And The Actual Costs For Infusion Of Immunobiologics In The Brazilian Public Healthcare System

    Oct 1, 2017, 00:00

  • Acceptance Of Indirect Comparisons In The German Early Benefit Assessment

    Oct 1, 2017, 00:00

  • Assessment of Hiv-Antiretroviral Adherence Using Refill Data From a National Administrative Database in Brazil

    Oct 1, 2017, 00:00

  • Broadening The Valuation Space In Health Technology Assessment- The Case of Monitoring Individuals With Ocular Hypertension

    Oct 1, 2017, 00:00

  • Real-World Prevalence Of Mild To Moderate Hypoglycemic Events In Portugal - Results From The Hipos-Pharma Study

    Oct 1, 2017, 00:00

  • Gender Differences In Heart Failure- The Arno Italian Experience

    Oct 1, 2017, 00:00

  • Financial Group Incentives Improving Medication Persistence - Health Behavior Engineering Approach

    Oct 1, 2017, 00:00

  • A Model To Predict Costs And Outcomes Associated With Hyperkalaemia In Patients With Chronic Kidney Disease Or Heart Failure

    Oct 1, 2017, 00:00

  • Managed Access Agreements (MAAS) In Appraisals Conducted By The National Institute For Health and Care Excellence (NICE)

    Oct 1, 2017, 00:00

  • Cognitive Interviewing During Linguistic Validation Of Clinical Outcomes Assessments (COAS)- In-Person Or Video Chat – An Analysis Of Respondent Preference

    Oct 1, 2017, 00:00

  • Patient Reported Outcome Of Celiac Disease

    Oct 1, 2017, 00:00

  • Feasibility And Acceptability Of Atrial Fibrillation Screening Using A Hand-Held ECG Device In General Practice Setting In Hong Kong

    Oct 1, 2017, 00:00

  • The Cost-Effectiveness Of Tavi In Intermediate Risk Patients In France

    Oct 1, 2017, 00:00

  • GLYCEMIC CONTROL IN PATIENTS WITH T2DM TREATED WITH SULFONYLUREAS ALONE OR IN COMBINATION WITH METFORMIN, ARGENTINA

    Oct 1, 2017, 00:00

  • Competency Analysis Of Community Pharmacists About Correct Use Of Metered Dose Inhaler

    Oct 1, 2017, 00:00

  • Modelling For Rare Diseases- Case of Canakinumab In Periodic Fever Syndromes In France

    Oct 1, 2017, 00:00

  • Pharmacoeconomic Results Of Highly Innovative Drugs Approved For Temporary Reimbursement In The Czech Republic

    Oct 1, 2017, 00:00

  • Finding The Patient In Clinical Meaningfulness Through Rigorous Cognitive Interviews

    Oct 1, 2017, 00:00

  • New Insights In Metastatic Colorectal Cancer Treatment (MCRC) In 5 European Countries

    Oct 1, 2017, 00:00

  • Racial Differences In The Prevalence of Cognitive Impairments And Dementia, Utilization of Chemo-Immunotherapy and Mortality In Elderly Diffuse Large B-Cell Lymphoma Patients

    Oct 1, 2017, 00:00

  • Choice of Instrument Impacts Healthcare Decisions- Effect of Source of Utility Derived from the Same Patient Population on Cost-Effectiveness

    Oct 1, 2017, 00:00

  • Real World Treatment Patterns And Resource Use For Advanced Non-Small Cell Lung Cancer In Brazilian Private Institutions

    Oct 1, 2017, 00:00

  • Increasing Trend On Turkish Un-Licenced Medicine Market- A General Overview Analysis

    Oct 1, 2017, 00:00

  • Prescription Costs Associated with A Pediatrician-Led Care Model Serving Children with Medical Complexities (CMC)

    Oct 1, 2017, 00:00

  • Evolution Cost-Effectiveness Analysis of Pharmaceutical Care for Type 2 Diabetes Mellitus

    Oct 1, 2017, 00:00

  • The Cost-Effectiveness of Nivolumab for The Treatment of People with Relapsed or Refractory Classical Hodgkin Lymphoma Following Autologous Stem Cell Transplant and Brentuximab Vedotin

    Oct 1, 2017, 00:00

  • Trends in Pragmatic Clinical Trials

    Oct 1, 2017, 00:00

  • Implications of the German HTA-Process on Market-Uptake of Oral Treatments for Type-2-Diabetes (T2DM) Since 2007

    Oct 1, 2017, 00:00

  • Identification of Real World Data Sources in Cancer in the Nordic Countries

    Oct 1, 2017, 00:00

  • Utilization and Evaluation of Delphi Panels In German Amnog Assessments

    Oct 1, 2017, 00:00

  • Comparison of The Quality of Life In Elderly Population According To The Occurrence of Femoral Neck Fracture

    Oct 1, 2017, 00:00

  • New Drugs Approval Timing In Italy (2015-2017)

    Oct 1, 2017, 00:00

  • The Prevalence Of Chronic Health Conditions And Multimorbidity In The Portuguese Population - Results From The 2014 National Health Interview Survey

    Oct 1, 2017, 00:00

  • Systematic Literarture Review of Health-Related Quality of Life In Clostridium Difficile Infection

    Oct 1, 2017, 00:00

  • Lacosamide As First Line Treatment Option In Focal Epilepsy; A Cost-Utility Analysis for The Greek Healthcare System

    Oct 1, 2017, 00:00

  • Real-World Multiple Myeloma Treatment Pattern In Lebanon- Evidence From Patient Chart Audit

    Oct 1, 2017, 00:00

  • Disease Progression in Pediatric Multiple Sclerosis- A Narrative Review

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Ferric Carboxymaltose (FCM) in the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease (IBD)

    Oct 1, 2017, 00:00

  • The Dynamics of Child Mental Health Care

    Oct 1, 2017, 00:00

  • Retrospective Analysis of Hospital Episode Statistics Data To Estimate The Economic Burden of Vaginal and Vulval Cancer in England (2009-2015)

    Oct 1, 2017, 00:00

  • The Budget Impact Of Introducing A PD-L1 Assay To Select Patients With Metastatic Nsclc Who Are Potential Candidates For Treatment With Immune Checkpoint Inhibitors

    Oct 1, 2017, 00:00

  • The Impact Of Obesity And Deprivation On HRQOL Gains Following Hip And Knee Replacements

    Oct 1, 2017, 00:00

  • But Will They Trade Health? Developing An Economic Value Framework for Oncology

    Oct 1, 2017, 00:00

  • Resource Utilization and Treatment of Patient with Hepatocelullar Carcinoma – A Microcosting Analysis

    Oct 1, 2017, 00:00

  • Achieving Key Objectives In Rare Diseases Healthcare Policy In Spain- Contribution From A Dravet Syndrome Working Group

    Oct 1, 2017, 00:00

  • Real-World Evaluation Of Physician Attitudes Towards The Prescription Of Androgen Deprivation Therapy For Patients With Prostate Cancer

    Oct 1, 2017, 00:00

  • Cost-Effectiveness And Impact Of New Innovative Treatments On Prognosis Of Melanoma And Ovarian Cancer For Australian Patients

    Oct 1, 2017, 00:00

  • Real World Treatment Patterns Of Patients With Ovarian Cancer Receiving First Line Chemotherapy In The United States

    Oct 1, 2017, 00:00

  • Comprehensive Knowledge and Uptake of Cervical Cancer Screening is Low Among Women Living with HIV/AIDS in Northwest Ethiopia

    Oct 1, 2017, 00:00

  • French People With MS And Their Caregivers Have To Financially Support Direct Non-Medical Costs Linked To Their Disease

    Oct 1, 2017, 00:00

  • The Cost-Effectiveness of Manufacturer Fees for Htas- Are They Promoting or Hindering Innovation?

    Oct 1, 2017, 00:00

  • Redets. 10 Years Of Full Economic Health Technologies Assessments (Medical Devices) In Spain (2006-2016)

    Oct 1, 2017, 00:00

  • Drugprice Developments After Patent Expiry

    Oct 1, 2017, 00:00

  • Predicting Dengue Fever Outbursts In Brazil- An Empirical Model Based On Climatic Parameters

    Oct 1, 2017, 00:00

  • Budget Impact of Ribociclib Plus Letrozole For The Treatment of Post-Menopausal Women With Hormone Receptor-Positive (HR+), Human Epidermal Growth Factor Receptor 2- Negative (HER2-) Advanced or Metastatic Breast Cancer From A US Private Th ...

    Oct 1, 2017, 00:00

  • The Utility of Different Approachs to Developing Health Utilities Data in Childhood Rare Diseases – A Case Study in Spinal Muscular Atrophy (SMA)

    Oct 1, 2017, 00:00

  • Cost Minimization Analysis and Budget Impact Model of Treatment of Chronic Hepatitis C Virus with Grazoprevir (Gzr, Mk - 5172 / Elbasvir (Ebr, Mk - 8742) in Patients with Genotypes 1 and 4 in Mexico

    Oct 1, 2017, 00:00

  • Body Piercings- Epidemiological Study on a Representative Sample of 5,000 French Subjects

    Oct 1, 2017, 00:00

  • A Conceptual Yet Pragmatic Framework for Value-Based Agreements

    Oct 1, 2017, 00:00

  • The Use of Published Real-World Evidence In HTA- An Analysis Of The Evidence Base Of Company Submissions In 2016 Nice Appraisals

    Oct 1, 2017, 00:00

  • Quality Of Life In Patients With Knee Arthritis In Slovak Republic

    Oct 1, 2017, 00:00

  • Health Economic Evaluations in Inflammatory Bowel Disease in Brazil- A Systematic Review

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of Sacubitril/Valsartan In The Treatment Of Heart Failure In Colombia

    Oct 1, 2017, 00:00

  • The Occurrence and Territorial Distribution of Acute Myocardial Infarctions in Hungary

    Oct 1, 2017, 00:00

  • Resource Use, Health Care Costs And Burden Of Disease In Patients With Polycythemia Vera In Finland- Evaluation Based On Leukocyte Counts Using Finnish Real World Data From Auria Biobank

    Oct 1, 2017, 00:00

  • A Retrospective Analysis Of Surgery Time For Echo PS™ Positioning System With Ventralight™ St VS Flat Mesh By Size In Outpatient Hospital Laparoscopic Hernia Repair Procedures

    Oct 1, 2017, 00:00

  • Patients Acknowledge Adaptation- The Case Of Amputees

    Oct 1, 2017, 00:00

  • The Impact of Rheumatoid Arthritis (RA) on a Patient’s Ability to Stay in Work and Level of Pain Experienced

    Oct 1, 2017, 00:00

  • An Evaluation of the Utilisation and Expenditure on Dual Antiplatelet Therapy (DAPT) in Ireland

    Oct 1, 2017, 00:00

  • Direct Medical Costs In The Year Of Mortality For Patients With Diabetes- A Population-Based Patient-Level Analysis

    Oct 1, 2017, 00:00

  • Selective Internal Radiotherapy (SIRT) in Metastatic Colorectal Cancer Patients with Liver Metastases- Preliminary Primary Care Resource Use and Utility Results from The Foxfire Randomised Controlled Trial

    Oct 1, 2017, 00:00

  • A Comparative Study Between Hypertensive Patients with and without Co-Morbidities; Knowledge, Acceptance of Illness and Quality of Life as Quantifiable Variables in KPK, Pakistan

    Oct 1, 2017, 00:00

  • Early Access To Medicines Pathways – Results Of A Global Survey

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Trifluridine/Tipiracil for The Treatment of Metastatic Colorectal Cancer in Portugal

    Oct 1, 2017, 00:00

  • Exploring Structural Uncertainty With An Open-Source Cost-Effectiveness Model For Rheumatoid Arthritis

    Oct 1, 2017, 00:00

  • Crohn’s Disease in Germany- A Claims Data Analysis of Therapies with Biological Agents

    Oct 1, 2017, 00:00

  • The Influence Of Age On Patient Attitudes And Acceptability Towards Using Their Own Mobile Device To Record Patient-Reported Outcomes Data In Clinical Trials

    Oct 1, 2017, 00:00

  • A Path Analysis of Effects of Patients’ Underlying Conditions, Treatment Satisfaction And Adherence on Quality of Life Among Korea Glaucoma Patients- Results From Korea Glaucoma Outcomes Research

    Oct 1, 2017, 00:00

  • Cost Utility Analysis of Infliixmab and Adalimumab Compared with Conventional Therapy in Patients with Crohn Disease in the Islamic Republic of Iran

    Oct 1, 2017, 00:00

  • Real World Treatment Patterns In The Neurogenic Bladder Population- A Systematic Literature Review

    Oct 1, 2017, 00:00

  • Cambios En La Calidad De Vida Relacionada Con La Salud De Pacientes Sometidos A Preparación Intestinal

    Oct 1, 2017, 00:00

  • Economic Assessment of NT-PROBNP Test for Acute Heart Failure at Brazilian Private Payer Perspective

    Oct 1, 2017, 00:00

  • Identification of Assessment and Funding Models Applicable to Companion Diagnostics in UK, France And Germany

    Oct 1, 2017, 00:00

  • Real World Effectiveness of Treatment With OBV/PTV/R ± DSV In HCV Patients With Cirrhosis In Poland

    Oct 1, 2017, 00:00

  • How Will Payers Manage the Cost of New, Advanced Biologic and Oncologic Agents as Therapy Areas Become Crowded with Drugs with Similar Mechanisms of Action?

    Oct 1, 2017, 00:00

  • Listening to the “Patient Voice” to Improve Design and Interpretation of Secondary Analyses- An Example in Atrial Fibrillation

    Oct 1, 2017, 00:00

  • Cost Analysis Of Drug-Related Probelms In Saudi Arabia, Patient And Health Care Professional's Perspective

    Oct 1, 2017, 00:00

  • Cost Containment And Privatisation Of Pharmaceutical Care In Gree A Review Of Policy Reforms Under The Memorandums’ Requirements

    Oct 1, 2017, 00:00

  • Psychotropic Drug Use in Non Psychiatric Wards- Indian Scenario

    Oct 1, 2017, 00:00

  • Cost-Effectiveness and Budget Impact of New Therapies for Metastatic Melanoma in Italy

    Oct 1, 2017, 00:00

  • Second-Line Treatments For Advanced Gastric Cancer- A Network Meta-Analysis Of Overall Survival Using Parametric Modelling Methods

    Oct 1, 2017, 00:00

  • Análise De Significância Do Banco De Dados Da Saúde Suplementar – Ss No Brasil, Sob As Perspectivas Dos Atendimentos Em Hospitais E Demais Prestadores Particulares

    Oct 1, 2017, 00:00

  • Linguistic Validation Of Knowledge, Attitudes And Practice Of Zika Virus Disease Questionnaire Among The Malaysian General Public Using Rasch Model- A Cross-Sectional Study

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Inflectra® Vs. Remicade® for Ankylosing Spondylitis in Germany

    Oct 1, 2017, 00:00

  • Quality of Life and Economic Burden Among Chronic Obstructive Pulmonary Disease (Copd) Patients in Japan

    Oct 1, 2017, 00:00

  • An Effective Tablet Program For Collecting Pain Data From Patients

    Oct 1, 2017, 00:00

  • A Business Case For Stroke Reduction Initiatives In Atrial Fibrillation- 3-Year Financial Projections For Three UK Regions

    Oct 1, 2017, 00:00

  • Evaluating The Real-Life Daily-Cost of Treatment With Antiepileptic Drugs In Fran A Study Based on The Combination Of French National Health Insurance Public Database, and The EMR LPD Private Database

    Oct 1, 2017, 00:00

  • Estimating the Value of Patient Engagement Outcomes in Precision Medicine to Eliminate Health Disparities in US American Indian Tribal Communities- Discriminant Analysis

    Oct 1, 2017, 00:00

  • Calibrating Model-Consistent Transition Probabilities For Fibrosis Stages In NASH

    Oct 1, 2017, 00:00

  • The Economic Impact of Optimizing Therapy In ‘Hard-To-Treat’ and ‘Harder-To-Treat’ Hypothyroid Patients by Changing the Levothyroxine Formulation from Tablets to Gel Caps

    Oct 1, 2017, 00:00

  • Anti-Thrombotic Therapy For Patients With Venous Thromboembolism In A Nationwide Health Plan

    Oct 1, 2017, 00:00

  • Nice and single? Recommendation Rates Of Oncology Therapies Approved On Clinical Trial Packages Lacking Comparative Phase 3 Data

    Oct 1, 2017, 00:00

  • Comparative Efficacy and Safety of Regimens for Treating Plasmodium Falciparum Malaria- A Systematic Review And Network Meta-Analysis

    Oct 1, 2017, 00:00

  • An Evaluation Of The Budget Impact Of The New 20% Subcutaneous Immunoglobulin (IG20GLY) For The Management Of Primary Immunodeficiency Diseases In Switzerland

    Oct 1, 2017, 00:00

  • Disclosure of Traditional and Complementary Medicine Used During Pregnancy and the Postpartum Period to Healthcare Providers

    Oct 1, 2017, 00:00

  • Creating Individualized HBA1C Targets Using Predictive Modeling

    Oct 1, 2017, 00:00

  • EQ-5D-5L Utility Values For Spanish Patients With Painful Chronic Osteoarthritis, Low-Back-Pain Or Cancer Pain

    Oct 1, 2017, 00:00

  • The Cost-Effectiveness of Pegaspargase for First-Line Treatment of Acute Lymphoblastic Leukaemia- A Cost-Utility Analysis

    Oct 1, 2017, 00:00

  • Impact of Different Baseline Definitions on The Incidence of Relevant Outcomes Associated with Cancer Following An Advanced Non-Small Cell Lung Cancer (NSCLC) Diagnosis

    Oct 1, 2017, 00:00

  • Comparison of Recent Hta Appraisals of Orphan Drugs By Nice, SMC And Has In 2015-2017

    Oct 1, 2017, 00:00

  • Age and Gender Relationships with Systemic Corticosteroid Induced Morbidity in Asthma- A Case-Control Study

    Oct 1, 2017, 00:00

  • Epidemiology of Locally Advanced or Metastatic Urothelial Cancer In The US, Europe And Japan

    Oct 1, 2017, 00:00

  • Hepatitis A and Hepatitis B Recombinant Vaccine Adherence In The United States

    Oct 1, 2017, 00:00

  • Real World Comparison of Persistence And Adherence Among Biologic Naïve Patients Initiating Apremilast or Biologics for The Treatment of Psoriasis In The United States

    Oct 1, 2017, 00:00

  • Barreras Y Facilitadores Para La Cobertura De Peritoneodiálisis En Chile

    Oct 1, 2017, 00:00

  • Tasas De Hospitalización De Los Pacientes Con Defectos De La Coagulación (Demanda Y Profilaxis) EN UNA Aseguradora Colombiana

    Oct 1, 2017, 00:00

  • Análisis De La Relaciones De Mercado Entre El Seguro Obligatorio Y El Seguro Voluntario Para El Caso Colombiano

    Oct 1, 2017, 00:00

  • Costs of Managing Hypoglycaemias Among Insulin-Treated Patients with Diabetes- Results from the Hat Study in Brazil

    Oct 1, 2017, 00:00

  • How well does the leading pharmaceutical reform model work in china? --an interrupted time series analysis

    Oct 1, 2017, 00:00

  • The Impact of Treatment-Free Remission of Tasigna® for Cml Patients in China – A Cost Effectiveness Analysis

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of four Surgical Strategies for the Treatment of Functional Menorrhagia in France

    Oct 1, 2017, 00:00

  • Characteristics of Psoriasis Patients In Latin America

    Oct 1, 2017, 00:00

  • Evaluating Patient Reported Outcomes Commonly Used In Current Lung Cancer Clinical Trials

    Oct 1, 2017, 00:00

  • Secukinumab As A More Efficient Alternative For The Treatment of Ankylosing Spondylitis- A Cost Per Responder Analysis Versus Adalimumab And Golimumab From A Peruvian Perspective For Private And Public Health Schemes

    Oct 1, 2017, 00:00

  • An Economic Evaluation Of Single Tablet Regimens Of Antiretroviral Therapy For Treatment-Naitve Hiv-Infected Patients

    Oct 1, 2017, 00:00

  • Assessing The Economic Impact Of The Introduction Of Daclatasvir In Combination With Asunaprevir For The Treatment Of Chronic Hepatitis C In China

    Oct 1, 2017, 00:00

  • Value Communication Strategies for Immunotherapies in Nsclc- A Quick Evidence Assessment from The UK

    Oct 1, 2017, 00:00

  • Budget Impact Analysis Of Incisional Hernia Repairs Considering Poly-4-Hydroxybutyrate Resorbable Meshes

    Oct 1, 2017, 00:00

  • Evidence Map of Indirect Costs In Psoriasis and Psoriatic Arthritis Since 1960

    Oct 1, 2017, 00:00

  • Evaluation of Anti-Asthmatic Potential of Artemisia Pallens Walls In Ovalbumin-Induced Airway Hyperresponsiveness in Laboratory Rats

    Oct 1, 2017, 00:00

  • Factors Contributing To The National Drug Expenditure Of Korea, 2010-2015- Focusing On The Core Therapeutic Classes

    Oct 1, 2017, 00:00

  • Forecasting The Potential Public Health Impact of Herpes Zoster Vaccination In Italy

    Oct 1, 2017, 00:00

  • Preferences Of The General Public For Reimbursement Criteria For Expensive Drugs- A Multi Criteria Decision Analysis For Rituximab And Bevacizumab

    Oct 1, 2017, 00:00

  • Evaluating The Clinical Effectiveness of Trastuzumab Emtansine (T-DM1) Versus All Other Treatments For Previously Treated, Unresectable, HER2-Positive Metastatic Breast Cancer (MBC)- A Mixed Treatment Comparison (MTC)

    Oct 1, 2017, 00:00

  • Análisis De Costo-Efectividad De La Monoterapia Con Rasagilina Comparada Con Pramipexol Para EL Manejo De Los Síntomas Motores En Pacientes Con Enfermedad De Parkinson Inicial En Colombia

    Oct 1, 2017, 00:00

  • Heterogeneous Preferences in the Adjunct Drug Treatment of Severe Hypercholesterolemia- A Latent-Class Analysis

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Bariatric Surgery Compared to Conventional Treatment From A Societal Perspective In Germany, France, Italy And The UK

    Oct 1, 2017, 00:00

  • Cost-Consequence Analysis of Using Neurofarmagen In The Decision-Making Process During The Treatment of Patients With Depression In The U.S

    Oct 1, 2017, 00:00

  • Retrospective Study On Italian Adpkd Disease Management Cost (REINA STUDY)

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Ribociclib Plus Letrozole Versus Palbociclib Plus Letrozole for Postmenopausal Women with Hormone Receptor-Positive (HR+), Human Epidermal Growth Factor Receptor 2-Negative (HER2–) Advanced/Metastatic Breast Cancer fro ...

    Oct 1, 2017, 00:00

  • Economic Evaluation of Exemestane Versus Tamoxifen in Post-Menopausal Women with Early Breast Cancer from The Egyptian Health Care System Perspective

    Oct 1, 2017, 00:00

  • Improving Transparency In Health Technology Assessment

    Oct 1, 2017, 00:00

  • Ameliorative Effect of Morin, A Bioflavonoid on Freund’s Adjuvant induced Established Polyarthritis in Rats

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of Stereotaxic Eeg (SEEG) As A Preoperative Diagnostic Procedure In Epilepsy Surgery

    Oct 1, 2017, 00:00

  • Effect of Health System, Financing, and Macro-Economic Characteristics on The Migration of Foreign Physicians To Oecd Countries

    Oct 1, 2017, 00:00

  • Psoriatic Arthritis Limits Patients’ Ability to Contribute to Society As Part of the Workfor Results from A Multi-National Survey Including Latin America

    Oct 1, 2017, 00:00

  • Comparison Of Food And Drug Administration, European Medicine Agency And Swissmedic New Drug Approval- An Assessment Of The International Harmonization

    Oct 1, 2017, 00:00

  • Effect of Acrylic Monofocal Intraocular Lenses (IOLS) on ND-YAG Laser Capsulotomy Rates- A Meta-Analysis

    Oct 1, 2017, 00:00

  • An Analysis of Translation Challenges When Adapting The Picture Naming Subtest of The Repeatable Battery for The Assessment of Neuropsychological Status (RBANS) for Use In Multinational Studies

    Oct 1, 2017, 00:00

  • Health Insurance Cost of Affective Disorders In Hungary- A Cost of Illness Study

    Oct 1, 2017, 00:00

  • Un Marco Conceptual Para El Análisis De La Implementación De Los Componentes De La Salud Electrónica (E-Salud) Y Su Efecto En La Calidad En La Provisión De Servicios De Salud

    Oct 1, 2017, 00:00

  • Estudos Econômicos De Belimumabe No Tratamento Do Lúpus Eritematoso Sistêmico - Uma Revisão Sistemática

    Oct 1, 2017, 00:00

  • Investigating The Economic Impact Of HIV-Associated Renal And Bone Co-Morbidities In UK Inpatients Using The Hes Database

    Oct 1, 2017, 00:00
  • «
  • 71
  • 72
  • 73
  • 74
  • 75 (current)
  • 76
  • 77
  • 78
  • 79
  • 80
  • »